HDAC6 inhibitor WT-161 shows anti-melanoma effects in vitro
Jan. 23, 2025
Melanoma is responsible for about 80% of skin cancer deaths worldwide, particularly in cases with metastasis. Melanoma shows resistance to standard therapy and the search for novel treatment options is a medical need.